Mustang Bio Inc (NASDAQ:MBIO) does about 29.92M shares in volume on a normal day but saw 1242557 shares change hands in the recent trading day. The company now has a market cap of 13.62M USD. Its current market price is $0.39, marking an increase of 4.55% compared to the previous close of $0.37. The 52 week high reached by this stock is $3.78 whilst the lowest price level in 52 weeks is $0.13.
Mustang Bio Inc (MBIO) has a 20-day trading average at $0.3366 and the current price is -89.79% off the 52-week high compared with 201.33% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3817 and its 200-day simple moving average is $0.8792. If we look at the stock’s price movements over the week, volatility stands at 13.10%, which increases to 15.20% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 55.02 to suggest the stock is neutral.
The consensus objective for the share price is $10.00, suggesting that the stock has a potential upside of 96.1% over the period.
2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 18, 2021 when BTIG Research initiated the stock to “Buy” and issued a price target of $11. Cantor Fitzgerald initiated its price target at $7.
Mustang Bio Inc (MBIO) stock is up 11.24% over the week and 20.29% over the past month. Its price is -71.41% year-to-date and -88.16% over the past year.
To reach the target analysts have set, the stock logically needs to grow 96.1 percent from here.
The company has a return on equity of -1191.31%. The beta has a value of 1.96.
